While thromboprophylaxis reduces venous thromboembolism and pulmonary embolism in hospitalized medical patients, it does not improve mortality and carries a small risk of major bleeding, highlighting the need for targeted patient selection.
No takes yet. Share an insight, caveat, or question.
Reduces asymptomatic VTE without mortality benefit in medical inpatients; leaves open optimal risk-based selection for prophylaxis.
Sam Schulman (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: